fbpx

PSA signs agreement to acquire the Australasian College of Pharmacy

The Pharmaceutical Society of Australia (PSA) is excited to announce an agreement to acquire the Australasian College of Pharmacy (ACP) was signed on 20 October 2025. The acquisition of ACP is part of PSA’s plan to expand educational opportunities, and grow PSA’s role as the premier education and training provider for pharmacists, pharmacy assistants and technicians. 

 

There are still steps to be completed before the settlement of the acquisition. It is expected that the acquisition it will be finalised by the end of the year (2025). 

Frequently Asked Questions

Why has the PSA Board decided to acquire ACP?

The decision to acquire ACP is part of the PSA Board’s broader plan to maximise member value through growth, expanding education opportunities for the profession, and securing a long-term, sustainable future for PSA as the premier training and education provider for pharmacists and pharmacy assistants and technicians.

What steps have been taken to progress the acquisition and when will it be finalised?

At the PSA Special General Meeting on 19 February 2025, PSA members voted overwhelmingly (95%) in support of constitutional amendments to enable the acquisition of the ACP. 

 

PSA proceeded to negotiate the terms of the acquisition and the finalisation of the Shares Purchase Agreement with the current shareholders of the ACP. 

 

PSA proceeded to ensure all regulatory issues were addressed. 

 

On 20 October 2025 the PSA Board voted unanimously to enter into a Share Purchase Agreement (contract) with shareholders of the ACP to formally acquire the ACP. 

 

Before final settlement occurs, additional legal matters related to the Share Purchase Agreement will be addressed, with the expectation the acquisition is finalised before the end of the calendar year. 

Will there be any changes to PSA's product offerings?

Until the acquisition is finalised, PSA’s products and services will continue unchanged. 

 

Once the acquisition has been completed, PSA’s education offering and CPD library is expected to grow as more resources can be invested in our education capabilities. 

 

PSA’s objects and mandate as the peak body representing all pharmacists will not change. This means, PSA will continue to be the body representing and supporting all pharmacists across all areas of practice. 

What does this mean for PSA members?

Until the acquisition is finalised, PSA’s products and services will continue to be provided to members unchanged.  

 

Once the acquisition has been completed, PSA’s education offering and CPD library is expected to grow as more resources can be invested in our education. 

 

PSA members can expect greater support and increased focus on high quality education to meet the growing needs of pharmacists in all areas of practice, and the broader pharmacy workforce.

Where can I find out more information if I have questions?

If you have questions regarding PSA’s acquisition of ACP, you can: 

  • call our membership team on 1300 369 772 (business hours AEDT)